December, 1 2022 in Articles

Streamline the AAV Manufacturing Process with High-Grade Starting Materials

 Streamline the AAV Manufacturing Process with High-Grade Starting Materials Authors:

By Forge Biologics

November, 16 2022 in Articles

Innovative Analytical Ultracentrifugation Techniques for the Characterization of AAV Vectors

Authors:

By Forge Biologics

November, 3 2022 in Articles, Videos

What the DMF! Spotlight on Forge's Drug Master File

Gene therapy developers' Investigational New Drug (IND) application process is arduous...

By Forge Biologics

August, 23 2022 in Articles

She Forges Turns 1: Reflecting on a Year of Celebrating, Supporting, and Elevating Women at Forge

By Forge Biologics

August, 12 2022 in Articles

Addressing the ‘Capacity Crunch’ with a Scalable Platform Process Approach

Authors: Brianna Barrett, Ph.D., Associate Director, Technical Sales, Forge Biologics ...

By Forge Biologics

February, 28 2022 in Articles

Forge Commemorates Rare Disease Day

By Forge Biologics

February, 11 2022 in Articles

Women Forging Change

At Forge, we believe wholeheartedly that people are our greatest asset. February 11th is...

By Forge Biologics

September, 1 2021 in Articles, Videos

Forge Ahead Launches with Support for Be The Match…and “HOPE” on a Summit

In August 2021, roughly a year since inception, Forge Biologics launched its Forge Ahead ...

By Forge Biologics

June, 1 2021 in Articles

Pennsylvania and Georgia become the 9th and 10th states to test for Krabbe disease in newborns

By Forge Biologics

January, 21 2021 in Articles

RESKUE Trial for Patients with Krabbe Disease

RESKUE Trial for Patients with Krabbe Disease January 21, 2021 by Dan Salvo With...

By Forge Biologics

Insights